InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,288.62
(
0.31%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CT

Send PM Follow Ignore
Followers 3
Posts 148
Boards Moderated 0
Alias Born 07/08/2002

CT

Re: semi_infinite post# 225999

Friday, 08/23/2019 12:48:28 PM

Friday, August 23, 2019 12:48:28 PM

Post# of 252302
FGEN subject to remaining overhang of doubt regarding MACE data (+adcom). Then on the business side, it remains to be seen 1) if FGEN can access the NDD patient population and 2) if/how China will cover roxa for patients. Just my quick thoughts.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up